Stivarga Approved for GIST in EU
The European Commission recently announced that Stivarga (regorafenib) from Bayer has been approved in the European Union (EU) as a third line treatment for GIST.
Here Comes the Sun: Skin Protection Tips for GIST Patients
As wonderful as the sun feels, especially after the harsh winter many of us experienced, its effects are cause for concern, especially for patients already challenged with skin issues. Keep reading to learn some skin protection tips for GIST patients.
Lancet Oncology Publishes List of Drugs to Avoid for Patients on Tyrosine Kinase Inhibitors
Lancet Oncology, a comprehensive overview of known or suspected drug-drug interactions between tyrosine-kinase inhibitors (Gleevec, Sutent, Stivarga) prescribed for GIST.
FDA Supports Patient Perspective to Promote Pharmaceutical Innovation
Dr. Janet Woodcock, director of the Center for Drug Evaluation and Research spoke to the House of Representatives about patient perspective.
FDA Receives Treatment Guidance from Patient Advocates
Patient advocacy is a vital component in assuring that roadblocks to optimal treatment do not prevent cancer patients from obtaining the help they deserve. Recently, a group from Parent Project Muscular Dystrophy presented the FDA [...]
Personalized Medicine: Paradigm of the Future for Cancer Treatment
Personalized or targeted medicine is the paradigm of the future: treatment options customized for individual patients.
Writing to Fight GIST – The Pen Is a Mighty Weapon Against Stress
Living with GIST can be stressful. There are many coping mechanisms to deal with chronic disease, but one that you may not have used in the past is one that others coping with stress have found enormously helpful: writing.
Cancer Drug Nivolumab Receives Regulatory Approval in Japan
A recent article from FierceBiotech announced that theAnti-PD-1 cancer drug nivolumab, a fully human antibody, received regulatory approval in Japan.
21st Century Cures Hearing In Washington D.C.
Marshall Summar, MD to testify on behalf of NORD at 21st Century Cures Hearing in Washington, D. C. on Friday, July 11 at 9 AM ET.
GIST Awareness Day Highlighted in New Press Release
Coverage of GIST Awareness Day continues with this press release that calls attention to our awareness campaign and our support for the global GIST community.